• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床I期非精原细胞瘤性生殖细胞肿瘤腹腔镜与开放腹膜后淋巴结清扫术后的生活质量:一项比较研究。

Quality of life after laparoscopic and open retroperitoneal lymph node dissection in clinical Stage I nonseminomatous germ cell tumor: a comparison study.

作者信息

Poulakis Vassilis, Skriapas Konstantinos, de Vries Rachelle, Dillenburg Wolfgang, Ferakis Nikolaos, Witzsch Ulrich, Becht Edward

机构信息

Department of Urology, Northwest Hospital, Stiftung Hospital zum Heiligen Geist, Frankfurt am Main, Germany.

出版信息

Urology. 2006 Jul;68(1):154-60. doi: 10.1016/j.urology.2006.01.023. Epub 2006 Jul 3.

DOI:10.1016/j.urology.2006.01.023
PMID:16820195
Abstract

OBJECTIVES

To compare the postoperative quality of life (QOL) and reconvalescence in patients with clinical Stage I nonseminomatous germ cell tumor (NSGCT) after laparoscopic retroperitoneal lymph node dissection (L-RPLND) and the open procedure (O-RPLND).

METHODS

Twenty-one patients with NSGCT who underwent transperitoneal L-RPLND were matched and compared with 29 patients who underwent O-RPLND. The operative, QOL, and recovery data and complications and cure rates were analyzed for both groups.

RESULTS

The mean follow-up time for the L-RPLND and O-RPLND groups was 14 months (range 6 to 20) and 26 months (range 8 to 38), respectively. No major complication requiring open surgical revision or prolongation of hospitalization was observed intraoperatively or postoperatively in either group. However, the early and late minor postoperative complications were significantly greater in the O-RPLND group than in the L-RPLND group (P <0.001). The L-RPLND patients had a significantly shorter hospitalization, greater QOL scores, and a faster return to normal activities than did the O-RPLND patients (all P <0.001).

CONCLUSIONS

L-RPLND for patients with clinical Stage I NSGCT is a safe and efficacious procedure, with a faster reconvalescence and greater postoperative QOL than after O-RPLND.

摘要

目的

比较临床I期非精原细胞瘤性生殖细胞肿瘤(NSGCT)患者行腹腔镜腹膜后淋巴结清扫术(L-RPLND)与开放手术(O-RPLND)后的术后生活质量(QOL)和康复情况。

方法

将21例行经腹L-RPLND的NSGCT患者与29例行O-RPLND的患者进行匹配和比较。分析两组的手术、QOL、恢复数据以及并发症和治愈率。

结果

L-RPLND组和O-RPLND组的平均随访时间分别为14个月(范围6至20个月)和26个月(范围8至38个月)。两组术中或术后均未观察到需要开放手术修正或延长住院时间的重大并发症。然而,O-RPLND组术后早期和晚期的轻微并发症明显多于L-RPLND组(P<0.001)。L-RPLND患者的住院时间明显更短,QOL评分更高,恢复正常活动的速度比O-RPLND患者更快(均P<0.001)。

结论

对于临床I期NSGCT患者,L-RPLND是一种安全有效的手术,与O-RPLND相比,康复更快,术后QOL更高。

相似文献

1
Quality of life after laparoscopic and open retroperitoneal lymph node dissection in clinical Stage I nonseminomatous germ cell tumor: a comparison study.临床I期非精原细胞瘤性生殖细胞肿瘤腹腔镜与开放腹膜后淋巴结清扫术后的生活质量:一项比较研究。
Urology. 2006 Jul;68(1):154-60. doi: 10.1016/j.urology.2006.01.023. Epub 2006 Jul 3.
2
Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.腹腔镜腹膜后淋巴结清扫术:在临床I期非精原细胞瘤性睾丸癌的治疗中仍有作用吗?欧洲视角。
Eur Urol. 2008 Nov;54(5):1004-15. doi: 10.1016/j.eururo.2008.08.022. Epub 2008 Aug 13.
3
[Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].改良腹膜后淋巴结清扫术治疗睾丸非精原细胞性生殖细胞肿瘤的疗效
Ai Zheng. 2008 Dec;27(12):1302-6.
4
Laparoscopic and open retroperitoneal lymph-node dissection for clinical stage I nonseminomatous germ-cell testis tumors.腹腔镜与开放腹膜后淋巴结清扫术治疗临床I期非精原细胞性生殖细胞睾丸肿瘤
J Endourol. 2006 Sep;20(9):627-31. doi: 10.1089/end.2006.20.627.
5
Oncologic efficacy of laparoscopic RPLND in treatment of clinical stage I nonseminomatous germ cell testicular cancer.腹腔镜保留神经的腹膜后淋巴结清扫术治疗临床I期非精原细胞性生殖细胞睾丸癌的肿瘤学疗效
Urology. 2007 Dec;70(6):1168-72. doi: 10.1016/j.urology.2007.08.041.
6
Long-term results of laparoscopic retroperitoneal lymph node dissection: a single-center 10-year experience.腹腔镜腹膜后淋巴结清扫术的长期结果:单中心10年经验
Urology. 2004 Mar;63(3):550-5. doi: 10.1016/j.urology.2003.09.067.
7
Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.化疗后腹膜后淋巴结清扫术治疗转移性非精原细胞瘤生殖细胞肿瘤患者的长期肿瘤学结果。
BJU Int. 2010 Sep;106(6):779-85. doi: 10.1111/j.1464-410X.2009.09175.x. Epub 2010 Jan 19.
8
Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumor: a large single institution experience.腹腔镜腹膜后淋巴结清扫术治疗临床 I 期非精原细胞瘤生殖细胞肿瘤:大型单机构经验。
J Urol. 2012 Feb;187(2):487-92. doi: 10.1016/j.juro.2011.10.035. Epub 2011 Dec 16.
9
Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.睾丸临床I期非精原细胞性生殖细胞肿瘤保留神经的腹膜后淋巴结清扫术的并发症:德国睾丸癌研究组的经验
J Urol. 2003 May;169(5):1710-4. doi: 10.1097/01.ju.0000060960.18092.54.
10
Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients.化疗后腹腔镜腹膜后淋巴结清扫术治疗低容量 II 期非精原细胞瘤生殖细胞肿瘤:前 100 例患者。
Eur Urol. 2013 Jun;63(6):1013-7. doi: 10.1016/j.eururo.2012.09.036. Epub 2012 Sep 24.

引用本文的文献

1
Survivorship Post-Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: A Systematic Review.转移性睾丸癌腹膜后淋巴结清扫术后的生存情况:一项系统综述
Int J Urol. 2025 Sep;32(9):1129-1136. doi: 10.1111/iju.70109. Epub 2025 May 14.
2
Clinical efficacy and safety of robotic retroperitoneal lymph node dissection for testicular cancer: a systematic review and meta-analysis.机器人辅助腹膜后淋巴结清扫术治疗睾丸癌的临床疗效与安全性:一项系统评价和荟萃分析
Front Oncol. 2023 Dec 19;13:1257528. doi: 10.3389/fonc.2023.1257528. eCollection 2023.
3
Laparoscopic retroperitoneal lymph node dissection versus open retroperitoneal lymph node dissection for testicular cancer: A comparison of clinical and perioperative outcomes.
腹腔镜下腹膜后淋巴结清扫术与开放性腹膜后淋巴结清扫术治疗睾丸癌的临床及围手术期结果比较
Asian J Urol. 2022 Apr;9(2):119-124. doi: 10.1016/j.ajur.2021.05.004. Epub 2021 May 25.
4
Clinical outcome of robot-assisted residual mass resection in metastatic nonseminomatous germ cell tumor.机器人辅助残留肿瘤切除治疗转移性非精原细胞瘤生殖细胞肿瘤的临床结果。
World J Urol. 2021 Jun;39(6):1969-1976. doi: 10.1007/s00345-020-03437-z. Epub 2020 Sep 21.
5
Robot-assisted laparoscopic retroperitoneal lymph node dissection: a minimally invasive surgical approach for testicular cancer.机器人辅助腹腔镜腹膜后淋巴结清扫术:一种用于睾丸癌的微创手术方法。
Transl Androl Urol. 2020 Jan;9(Suppl 1):S66-S73. doi: 10.21037/tau.2019.12.36.
6
Robot-assisted laparoscopic retroperitoneal lymph node dissection with concomitant inferior vena cava thrombectomy for metastatic mixed testicular germ cell cancer: a case report.机器人辅助腹腔镜下后腹膜淋巴结清扫术联合下腔静脉血栓切除术治疗转移性混合性睾丸生殖细胞癌:一例报告
J Med Case Rep. 2019 Aug 27;13(1):272. doi: 10.1186/s13256-019-2200-y.
7
A Review of Outcomes and Technique for the Robotic-Assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer.机器人辅助腹腔镜下睾丸癌腹膜后淋巴结清扫术的结果与技术综述
Adv Urol. 2018 May 3;2018:2146080. doi: 10.1155/2018/2146080. eCollection 2018.
8
Robot-assisted laparoscopic retroperitoneal lymph node dissection in clinical stage II testicular cancer.机器人辅助腹腔镜腹膜后淋巴结清扫术治疗 II 期睾丸癌。
J Robot Surg. 2008 Sep;2(3):189-91. doi: 10.1007/s11701-008-0093-7. Epub 2008 Jul 25.
9
Robotic Primary RPLND for Stage I Testicular Cancer: a Review of Indications and Outcomes.机器人辅助的I期睾丸癌根治性腹膜后淋巴结清扫术:适应证与治疗结果综述
Curr Urol Rep. 2016 May;17(5):41. doi: 10.1007/s11934-016-0597-z.
10
Laparoscopic retroperitoneal lymph node dissection for testicular cancer.腹腔镜下睾丸癌腹膜后淋巴结清扫术
Arab J Urol. 2012 Mar;10(1):66-73. doi: 10.1016/j.aju.2012.01.001. Epub 2012 Feb 14.